Back
Iterum Therapeutics PLC 10K Form
Buy
57
ITRM
Iterum Therapeutics PLC
Last Price:
1.28
Seasonality Move:
48.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-11-16 | 10Q | ITRM/Iterum Therapeutics PLC Quarterly |
| 2020-08-06 | 10K | ITRM/Iterum Therapeutics PLC Annual |
| 2020-05-14 | 10Q | ITRM/Iterum Therapeutics PLC Quarterly |
| 2020-03-12 | 10K | ITRM/Iterum Therapeutics PLC Annual |
| 2019-11-12 | 10Q | ITRM/Iterum Therapeutics PLC Quarterly |
| 2019-08-14 | 10Q | ITRM/Iterum Therapeutics PLC Quarterly |
Receive ITRM News And Ratings
See the #1 stock for the next 7 days that we like better than ITRM
ITRM Financial Statistics
Sales & Book Value
| Annual Sales: | $37K |
|---|---|
| Cash Flow: | $-13.08M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.37 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.65000 |
|---|---|
| Net Income (TTM): | $-35.58M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Iterum Therapeutics PLC Earnings Forecast
Key Iterum Therapeutics PLC Financial Ratios
- The Interest Expense is -3.72% of Operating Income.
- Per Share Earnings over the last 8 years have been positive in 5 years.
Iterum Therapeutics PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ITRM |
| CUSIP: | G6333L |
| Website: | iterumtx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ITRM Technical Analysis vs Fundamental Analysis
Buy
57
Iterum Therapeutics PLC (ITRM)
is a Buy
Is Iterum Therapeutics PLC a Buy or a Sell?
-
Iterum Therapeutics PLC stock is rated a Buy
The current Iterum Therapeutics PLC [ITRM] share price is $1.31. The Score for ITRM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.